Arcturus Therapeutics Ltd. Increase (Decrease) in Accounts Receivable
Arcturus Therapeutics Ltd. reported Increase (Decrease) in Accounts Receivable of -$24.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2019-05-13
- Arcturus Therapeutics Ltd. increase (decrease) in accounts receivable for the quarter ending 2019-03-31 was -$24.00K, a 103.44% decline year-over-year.
- Arcturus Therapeutics Ltd. increase (decrease) in accounts receivable for the quarter ending 2018-12-31 was $3.36M.
- Arcturus Therapeutics Ltd. increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was -$248.00K.
- Arcturus Therapeutics Ltd. increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was $194.00K.
- Arcturus Therapeutics Ltd. increase (decrease) in accounts receivable for fiscal 2018 was $4.00M.
- Arcturus Therapeutics Ltd. increase (decrease) in accounts receivable for fiscal 2017 was -$3.15M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$24.00K 10-Q · filed 2019-05-13 | $3.33M derived: sum of 2 quarters · filed 2019-05-13 | $3.09M derived: sum of 3 quarters · filed 2019-05-13 | $3.28M derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-12-31 | $3.36M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $3.11M derived: sum of 2 quarters · filed 2019-03-18 | $3.30M derived: sum of 3 quarters · filed 2019-03-18 | $4.00M 10-K · filed 2019-03-18 |
| 2018-09-30 | -$248.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | -$54.00K derived: sum of 2 quarters · filed 2018-11-07 | $643.00K 6-K · filed 2018-11-07 | $116.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-06-30 | $194.00K derived: 6-K 6 month − 10-Q 3 month · filed 2018-09-28 | $891.00K 6-K · filed 2018-09-28 | $364.00K derived: sum of 3 quarters · filed 2019-05-13 | -$375.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-03-31 | $697.00K 10-Q · filed 2019-05-13 | $170.00K derived: sum of 2 quarters · filed 2019-05-13 | -$569.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$527.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$1.27M derived: sum of 2 quarters · filed 2019-03-18 | -$3.15M 10-K · filed 2019-03-18 | |
| 2017-09-30 | -$739.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | -$2.63M 6-K · filed 2018-11-07 | ||
| 2017-06-30 | -$1.89M 6-K · filed 2018-09-28 | |||
| 2016-12-31 | $1.56M 20-F · filed 2018-05-14 | |||
| 2015-12-31 | $2.08M 20-F · filed 2018-05-14 |